Free Trial
OTCMKTS:PARD

Poniard Pharmaceuticals (PARD) Stock Price, News & Analysis

About Poniard Pharmaceuticals Stock (OTCMKTS:PARD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
2,479 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PARD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poniard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PARD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

PARD Stock Analysis - Frequently Asked Questions

Shares of PARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Poniard Pharmaceuticals investors own include Plug Power (PLUG), Devon Energy (DVN), DOW (DOW), Chevron (CVX), Corteva (CTVA), Constellation Energy (CEG) and Brenmiller Energy (BNRG).

Company Calendar

Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PARD
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.25
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:PARD) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners